P585: VENETOCLAX IN COMBINATION WITH INTENSIVE TREATMENT PROTOCOLS FOR PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA – A MULTICENTER REAL-WORLD ANALYSIS

• O. Wolach,
• A. Frisch,
• L. Shargian,
• M. Yeshurun,
• A. Apel,
• V. Vainstein,
• Y. Moshe,
• S. Shimony,
• O. Amit,
• Y. Bar On,
• Y. Ofran,
• P. Raanani,
• B. Nachmias,
• R. Ram

Affiliations

O. Wolach

1 Hematology, Rabin Medical Center, Petah Tikva

A. Frisch

2 Hematology, Rambam Health Care Campus, Haifa

L. Shargian

1 Hematology, Rabin Medical Center, Petah Tikva

M. Yeshurun

1 Hematology, Rabin Medical Center, Petah Tikva

A. Apel

3 Hematology, Shamir Medical Center, Zriffin

V. Vainstein

4 Hematology, Hadassah Medical Center, Jerusalem

Y. Moshe

5 Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv

S. Shimony

1 Hematology, Rabin Medical Center, Petah Tikva

O. Amit

5 Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv

Y. Bar On

5 Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv

Y. Ofran

6 Hematology, Shaare Zedek Medical Center, Jerusalem, Israel

P. Raanani

1 Hematology, Rabin Medical Center, Petah Tikva

B. Nachmias

4 Hematology, Hadassah Medical Center, Jerusalem

R. Ram

5 Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv